Guardant Health G&A decreased by 4.9% to $57.93M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 23.4%, from $46.95M to $57.93M. Over 4 years (FY 2021 to FY 2025), G&A shows relatively stable performance with a 0.6% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementIncome Statement
SectionOperating Expenses
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2016
Last reportedQ1 2026May 7, 2026
How to read this metric
A decrease as a percentage of revenue indicates improved operational leverage and administrative efficiency.
Detailed definition
General and administrative expenses cover the costs of supporting functions such as executive management, legal, finance...
Peer comparison
Standard across all industries; investors look for this to grow slower than revenue over time.
Metric ID:
general_and_administrativeHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $48.38M | $50.06M | $40.27M | $41.27M | $43.68M | $41.12M | $37.89M | $40.45M | $41.52M | $36.17M | $37.67M | $38.65M | $40.46M | $49.13M | $51.88M | $46.95M | $50.26M | $53.27M | $60.93M | $57.93M |
| QoQ Change | — | +3.5% | -19.5% | +2.5% | +5.8% | -5.9% | -7.9% | +6.7% | +2.6% | -12.9% | +4.1% | +2.6% | +4.7% | +21.4% | +5.6% | -9.5% | +7.0% | +6.0% | +14.4% | -4.9% |
| YoY Change | — | — | — | — | -9.7% | -17.8% | -5.9% | -2.0% | -5.0% | -12.0% | -0.6% | -4.4% | -2.5% | +35.8% | +37.7% | +21.5% | +24.2% | +8.4% | +17.4% | +23.4% |
Range$36.17M – $60.93M
CAGR+3.9%
Avg YoY Growth+6.8%
Median YoY Growth-1.3%
G&A at Other Companies
Frequently Asked Questions
- What is Guardant Health's g&a?
- Guardant Health (GH) reported g&a of $57.93M in Q1 2026.
- How has Guardant Health's g&a changed year-over-year?
- Guardant Health's g&a increased by 23.4% year-over-year, from $46.95M to $57.93M.
- What is the long-term trend for Guardant Health's g&a?
- Over 4 years (2021 to 2025), Guardant Health's g&a has grown at a 0.6% compound annual growth rate (CAGR), from $206.64M to $211.41M.
- What does g&a mean?
- The overhead costs of running the business that are not directly tied to production or sales.